Finance

Lists
Outlook: 52.0% bullish·16.0% bearish
Go to analysis
SYK:NYSE
Stryker Corp
US$297,40
+1,42%
(+4,16) 1D
16 ຕ.ລ., 10 ໂມງ 9 ນາທີ 39 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYK...
Open
US$295,89
High
US$299,67
Low
US$295,00
Mkt. cap
114,07 ຕື້
Avg. vol.
2,93 ລ້ານ
Volume
267,51 ພັນ
Dividend
1,18%
Quarterly dividend
US$0,88
Ex-dividend date
30 ກ.ຍ. 2026
P/E ratio
30,81
52-wk high
US$392,55
52-wk low
US$267,00
EPS
US$9,65
Beta
0,77
Shares outstanding
383,57 ລ້ານ
No. of employees
56 ພັນ
Open
US$295,89
High
US$299,67
Low
US$295,00
Mkt. cap
114,07 ຕື້
Avg. vol.
2,93 ລ້ານ
Volume
267,51 ພັນ
Dividend
1,18%
Quarterly dividend
US$0,88
Ex-dividend date
30 ກ.ຍ. 2026
P/E ratio
30,81
52-wk high
US$392,55
52-wk low
US$267,00
EPS
US$9,65
Beta
0,77
Shares outstanding
383,57 ລ້ານ
No. of employees
56 ພັນ
News stories
From web sources and news partners
GuruFocus
GuruFocus
·
16 ຊົ່ວໂມງກ່ອນ
Is It Too Late to Buy Stryker Corp (SYK) After 4.1% Rally? GF Va
Simply Wall Street
Simply Wall Street
·
17 ຊົ່ວໂມງກ່ອນ
Stryker (SYK) Wins FDA Clearance, Is The 9% Undervaluation Enough?
News Corp
News Corp
·
17 ຊົ່ວໂມງກ່ອນ
Stryker Corp. stock outperforms competitors on strong trading day
Profile
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States. The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
About Stryker Corp
CEOKevin A. Lobo
Employees56 ພັນ
Founded1941
Headquartersຄາລາມາຊູ, ລັດມິຊິແກນ, ສະຫະລັດ
SectorMedical device
Analyst ratings
Based on 20 analysts giving stock ratings to SYK in the past 3 months
Strong buy
Buy
18
Hold
2
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for SYK in the last 3 months.
Highest
Current US$297,40
US$420,00 (+41,23%)
Average
US$364,72 (+22,64%)
Lowest
US$298,00 (+0,20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vik Chopra
BMO Capital
Buy
Maintained
US$317,00
+6,6%
10/12/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
US$385,00
+29,5%
10/13/2026
Christopher Pasquale
Barclays
Buy
Maintained
US$375,00
+26,1%
10/13/2026
Ryan Zimmerman
BTIG
Buy
Maintained
US$316,00
+6,3%
10/12/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
US$353,00
+18,7%
10/12/2026
Joanne Wuensch
Citi
Buy
Maintained
-
-
10/07/2026
Travis Steed
Bank of America Securities
Buy
Maintained
US$380,00
+27,8%
10/06/2026
Matt Miksic
Barclays
Buy
Maintained
US$375,00
+26,1%
10/07/2026
Richard Newitter
Truist Financial
Hold
Maintained
US$310,00
+4,2%
10/06/2026
Michael Matson
Needham
Buy
Maintained
US$418,00
+40,6%
10/06/2026
Kendall Au
RBC Capital
Buy
Maintained
US$420,00
+41,2%
10/01/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
US$330,00
+11%
09/30/2026
Matthew Taylor
Jefferies
Buy
Maintained
US$405,00
+36,2%
09/22/2026
Mathew Blackman
TD Cowen
Hold
Reiterated
US$298,00
+0,2%
09/22/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
US$385,00
+29,5%
09/18/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
US$420,00
+41,2%
09/16/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
US$348,00
+17%
09/16/2026
Steven Lichtman
William Blair
Buy
Reiterated
-
-
09/09/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
US$350,00
+17,7%
08/04/2026
David Turkaly
Citizens JMP
Buy
Maintained
US$400,00
+34,5%
08/03/2026
Jayson Bedford
Raymond James
Buy
Maintained
US$370,00
+24,4%
07/31/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
US$390,00
+31,1%
07/31/2026
Patrick Wood
UBS
Buy
Upgraded
US$400,00
+34,5%
07/28/2026
David Toung
Argus Research
Buy
Reiterated
US$370,00
+24,4%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
US$418,00
+40,6%
07/08/2026
Unknown Analyst
BMO Capital
Buy
Initiated
US$369,00
+24,1%
07/09/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
US$350,00
+17,7%
07/06/2026
David Roman
Goldman Sachs
Hold
Maintained
US$361,00
+21,4%
05/01/2026
Jeff Johnson
Robert W. Baird
Buy
Maintained
US$385,00
+29,5%
05/01/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
US$315,00
+5,9%
05/01/2026
Lee Hambright
Bernstein
Buy
Maintained
US$410,00
+37,9%
05/01/2026
Nico Chen
DBS
Buy
Maintained
US$450,00
+51,3%
03/18/2026
Danielle Antalffy
UBS
Hold
Reiterated
US$380,00
+27,8%
03/17/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$465,00
+56,4%
03/05/2026
Next call ໃນອີກ 13 ມື້
ພະຫັດ 29 ຕ.ລ., 22:30
Fiscal period
Q3 2026
- / US$3,53
Revenue / Est. (USD)
- / 6,62 ຕື້
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
6,06 ຕື້
7,17 ຕື້
6,02 ຕື້
6,59 ຕື້
Cost of goods sold
2,12 ຕື້
2,49 ຕື້
2,19 ຕື້
2,08 ຕື້
Cost of revenue
2,12 ຕື້
2,49 ຕື້
2,19 ຕື້
2,08 ຕື້
Research and development expenses
409,00 ລ້ານ
388,00 ລ້ານ
409,00 ລ້ານ
429,00 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,99 ຕື້
2,15 ຕື້
2,16 ຕື້
2,13 ຕື້
Operating expense
2,58 ຕື້
2,72 ຕື້
2,75 ຕື້
2,73 ຕື້
Total operating expenses
4,71 ຕື້
5,22 ຕື້
4,95 ຕື້
4,81 ຕື້
Operating income
1,35 ຕື້
1,95 ຕື້
1,07 ຕື້
1,78 ຕື້
Other non operating income
-138,00 ລ້ານ
420,00 ລ້ານ
19,00 ລ້ານ
1,00 ລ້ານ
EBT including unusual items
1,03 ຕື້
1,70 ຕື້
850,00 ລ້ານ
1,56 ຕື້
EBT excluding unusual items
1,25 ຕື້
1,81 ຕື້
987,00 ລ້ານ
1,68 ຕື້
Income tax expense
170,00 ລ້ານ
856,00 ລ້ານ
105,00 ລ້ານ
288,00 ລ້ານ
Effective tax rate
16,52%
50,21%
12,35%
18,41%
Other operating expenses
-
-
-
-
Net income
859,00 ລ້ານ
849,00 ລ້ານ
745,00 ລ້ານ
1,28 ຕື້
Net profit margin
14,18%
11,84%
12,38%
19,37%
Earnings per share
3,19
4,47
2,60
3,69
Interest and investment income
28,00 ລ້ານ
31,00 ລ້ານ
34,00 ລ້ານ
26,00 ລ້ານ
Interest expense
-
-607,00 ລ້ານ
-148,00 ລ້ານ
-141,00 ລ້ານ
Net interest expenses
28,00 ລ້ານ
-576,00 ລ້ານ
-114,00 ລ້ານ
-115,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
1,66 ຕື້
2,27 ຕື້
1,37 ຕື້
2,08 ຕື້
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google